Digi.Bio
Latest round
- Seed
Last raised
- Mar 2017
Total raised
- Undisclosed
Investors
- 1
About Digi.Bio
Bio focuses on providing innovative solutions for single-cell analysis.Bio primarily offers a platform focused on single-cell profiling technology designed to enhance cell-based therapies. Their core product measures cellular dynamics, interactions, and therapeutic responses at a single-cell level, applicable to various therapeutic modalities, including engineered T cells and antibodies.Bio generates revenue through strategic partnerships and B2B transactions with clients in the biotechnology field. Their business model includes subscription and service agreements for access to their proprietary platform, complemented by technical support and consultation. The company aims to develop new products that enhance the capabilities of their current platform, although specific release dates have not been disclosed. They are also looking to penetrate additional geographic markets, particularly targeting expansion into Asia and Europe by 2024.
Who invested in Digi.Bio
1 investor across 1 round
See all investors in Digi.Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 30, 2017
Amount
Undisclosed
Investors
Questions about Digi.Bio
Who invested in Digi.Bio?
Digi.Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Digi.Bio raised?
Digi.Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Digi.Bio last raise money?
Digi.Bio's most recent round on record is a Seed, in Mar 2017.
What does Digi.Bio do?
Bio focuses on providing innovative solutions for single-cell analysis.
Where is Digi.Bio headquartered?
Digi.Bio is headquartered in Amsterdam, Netherlands.
Which VCs invest in companies like Digi.Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Digi.Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Digi.Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.